FindTrial
Sign In

Cutting balloon dilation compared with conventional balloon dilation for the Treatment of de novo Coronary Lesions with drug-eluting balloon in the real word

Cutting balloon dilation compared with conventional balloon dilation for the Treatment of de novo Coronary Lesions with drug-eluting balloon in the real word

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ORC-17012134
Enrollment
Unknown
Registered
2017-07-25
Start date
2017-07-26
Completion date
Unknown
Last updated
2017-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coronary heart disease

Interventions

two groups: cutting balloon

Sponsors

The Second Hospital of Hebei Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: All patients with successful drug-eluting balloon treatment for coronary artery disease and have three months of postoperative reexamination of IVUS image data

Exclusion criteria

Exclusion criteria: 1. Implanted stent patients; 2. Severe liver and renal insufficiency; 3. Severe calcified lesions; 4. Severe angulation lesions.

Design outcomes

Primary

MeasureTime frame
MLD;MLA;luminal loss;diameter stenosis;—

Countries

China

Contacts

Public ContactWang Mei

The Second Hospital of Hebei Medical University

wangmei86632@sina.com+86 13313038682

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026